Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Huabei Pharmaceutical Group And DSM Agree On Joint Ventures

This article was originally published in PharmAsia News

Executive Summary

Huabei Pharmaceutical Group and DSM drafted 19 initial agreements for joint projects last November, including increasing the former's capital, joint ventures on nutrition products, assets transfer and technology permission. Although the final agreements have not been signed, the draft raises the likelihood of the collaboration to proceed. Huabei Pharmaceutical has identified seven priorities for 2009, and will quickly finalize the joint ventures and introduce funds, technology and management. Analysts observe that the firm will extend its raw Vitamin C materials to downstream formulation business as well as transfer DSM's "green enzyme techniques" to produce penicillin, while DSM is poised to get a slice of China's huge market from the partnership. (Click here for more - Chinese Language)

You may also be interested in...

Abbott Launches Five-Minute POC Rapid COVID-19 Test

Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.

In A Bizarre Move, Trump Orders GM To Make Ventilators – Even Though The Auto Giant Already Is

President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.

Start-Up Spotlight: Iraq War Veteran Deploys ‘Bone Paint’ To Combat Traumatic Injuries

Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts